Literature DB >> 1626571

Peritoneal dialysis in end-stage renal disease patients with preexisting chronic liver disease and ascites.

R G Marcus1, J Messana, R Swartz.   

Abstract

PURPOSE: Hemodialysis in patients with chronic liver disease and ascites may be complicated by intradialytic hypotension, limiting the amount of ultrafiltration and resulting in massive ascites. Successful maintenance peritoneal dialysis (PD) has not been previously reported as an alternative to hemodialysis in this population. PATIENTS AND METHODS: Nine patients with chronic renal failure, chronic liver disease, and tense ascites prior to beginning PD are described. All chronic PD catheters were placed percutaneously by the nephrology staff. Seven patients were maintained primarily on continuous ambulatory peritoneal dialysis, whereas two were on intermittent peritoneal dialysis.
RESULTS: PD catheters were placed without serious hemorrhage or bowel injury. PD provided adequate clearance and volume maintenance for each patient. Fifteen episodes of peritonitis occurred in 18 patient-years of PD. All episodes of peritonitis were successfully treated with intraperitoneal antibiotics without catheter removal. Only one patient had a decline in the serum albumin level of 0.5 g/dL or more during the course of chronic PD. Three of the nine patients are still alive and on PD for durations of 18 to 24 months. One patient insidiously developed sclerosing peritonitis after 8 years on PD and is now on hemodialysis, and another patient switched to hemodialysis because she was no longer able to care for herself or to manage her PD. Four patients died while maintained on PD; three deaths were due to complications of liver failure within the first 4 months of PD and the fourth was due to empyema after 4 years of PD.
CONCLUSION: PD can be used successfully to treat chronic renal failure in patients with chronic liver disease and ascites when the liver disease itself is not rapidly fatal. PD may be better tolerated than hemodialysis and perhaps should be the renal replacement treatment of choice in these patients.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1626571     DOI: 10.1016/0002-9343(92)90677-4

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  8 in total

1.  Continuous ambulatory peritoneal dialysis (CAPD) in the management of persistent hepatic encephalopathy - more studies needed.

Authors:  Sivaramakrishnan Ramanarayanan; Shiv Kumar Sarin
Journal:  Perit Dial Int       Date:  2014 Nov-Dec       Impact factor: 1.756

2.  Cirrhotic ascites review: Pathophysiology, diagnosis and management.

Authors:  Christopher M Moore; David H Van Thiel
Journal:  World J Hepatol       Date:  2013-05-27

3.  Course of encephalopathy in a cirrhotic dialysis patient treated sequentially with peritoneal and hemodialysis.

Authors:  Suleyman Koz; Idris Sahin; Zafer Terzi; Sema Tulay Koz
Journal:  Case Rep Med       Date:  2015-03-25

4.  Liver cirrhosis leads to poorer survival in patients with end-stage renal disease.

Authors:  Ae Jin Kim; Hye Jin Lim; Han Ro; Ji Yong Jung; Hyun Hee Lee; Wookyung Chung; Jae Hyun Chang
Journal:  Korean J Intern Med       Date:  2016-03-26       Impact factor: 2.884

5.  Chronic renal dysfunction in cirrhosis: A new frontier in hepatology.

Authors:  Ramesh Kumar; Rajeev Nayan Priyadarshi; Utpal Anand
Journal:  World J Gastroenterol       Date:  2021-03-21       Impact factor: 5.742

6.  Prevalence and outcomes of chronic liver disease in patients receiving dialysis: systematic review and meta-analysis.

Authors:  Oscar Swift; Shivani Sharma; Sivaramakrishnan Ramanarayanan; Hamza Umar; Keith R Laws; Enric Vilar; Ken Farrington
Journal:  Clin Kidney J       Date:  2021-11-18

Review 7.  Peritoneal Dialysis Use in Patients With Ascites: A Review.

Authors:  Nilum Rajora; Lucia De Gregorio; Ramesh Saxena
Journal:  Am J Kidney Dis       Date:  2021-06-16       Impact factor: 8.860

8.  Peritoneal Dialysis in a Patient with Acute Kidney Injury, Thrombocytopenia, Urosepsis, and Liver Cirrhosis: A Case Report.

Authors:  Krzysztof Cieszyński; Alicja E Grzegorzewska
Journal:  Am J Case Rep       Date:  2020-10-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.